fundvisualizer.com

Invesco Dynamic Pharmaceuticals ETFPJP

Performance (before sales charge)

As of 12/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/29/2022
Stock
97.94%
Non-U.S. Stock
2.03%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.03%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/29/2022

Basic materials

0.00%

Consumer cyclical

0.00%

Financial services

0.00%

Real estate

0.00%

Consumer defensive

0.00%

Health care

99.97%

Utilities

0.00%

Communication services

0.00%

Energy

0.00%

Industrials

0.00%

Technology

0.00%

Top 10 holdings

As of 12/29/2022

Pfizer Inc
6.75%
Merck & Co Inc
6.74%
Abbott Laboratories
6.73%
AbbVie Inc
6.65%
Gilead Sciences Inc
6.47%
Eli Lilly and Co
6.44%
Johnson & Johnson
6.39%
Amgen Inc
5.81%
Horizon Therapeutics PLC
4.85%
Jazz Pharmaceuticals PLC
3.50%
Fund assets

$327.77 Million

Share class

--

Morningstar category

Health

Expense ratio

0.56%

Investment objective

Specialty - Health

Documents